GlassScriptPhysician profile
Dennis M Obrien
NPI 1568673903
$713.25
in general payments reported to CMS, 2019-2025
16 companies · $54.28 in 2025
The $54.28 reported for 2025 was less than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $101 · 2021: $45.74 · 2022: $26.53 · 2023: $20.03 · 2024: $203 · 2025: $54.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $173.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $98.29 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $76.66 | 2019-2025 | Ultomiris |
| Pfizer INC. | $76.58 | 2023-2024 | |
| Global Blood Therapeutics, INC. | $48.71 | 2020-2022 | |
| Fortovia Therapeutics, INC. | $34.30 | 2019 | |
| Chiesi USA, INC. | $28.26 | 2024 | Filsuvez |
| Pharming Healthcare, INC. | $26.97 | 2024 | Ruconest |
| Agios Pharmaceuticals, INC. | $26.58 | 2025 | Pyrukynd |
| Fennec Pharmaceuticals, INC. | $21.24 | 2024 | Pedmark |
| Jazz Pharmaceuticals INC. | $20.75 | 2024 | |
| Silvergate Pharmaceuticals, INC. | $19.46 | 2019 | |
| Rare Disease Therapeutics, INC. | $19.00 | 2024 | Purixan |
| Servier Pharmaceuticals LLC | $15.84 | 2021 | |
| Emmaus Medical, INC. | $15.06 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Btg International INC. | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.